208 related articles for article (PubMed ID: 36627626)
21. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
[TBL] [Abstract][Full Text] [Related]
22. Fecal carriage and molecular epidemiology of carbapenem-resistant Enterobacteriaceae from outpatient children in Shanghai.
Pan F; Tian D; Wang B; Zhao W; Qin H; Zhang T; Zhang H
BMC Infect Dis; 2019 Aug; 19(1):678. PubMed ID: 31370804
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
[TBL] [Abstract][Full Text] [Related]
24. Clinical significance and burden of carbapenem-resistant Enterobacterales (CRE) colonization acquisition in hospitalized patients.
Hassoun-Kheir N; Hussien K; Karram M; Saffuri M; Badaan S; Peleg S; Aboelhega W; Warman S; Alon T; Pollak D; Szwarcwort Cohen M; Paul M
Antimicrob Resist Infect Control; 2023 Nov; 12(1):129. PubMed ID: 37986092
[TBL] [Abstract][Full Text] [Related]
25. Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant
Peng C; Feng DH; Zhan Y; Wang Q; Chen DQ; Xu Z; Yang L
Microb Drug Resist; 2022 Jun; 28(6):698-709. PubMed ID: 35639427
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of blaOXA-181-positive isolates in patients admitted to two major hospital intensive care units in Kuwait.
Al Fadhli AH; Jamal WY; Rotimi VO
PLoS One; 2020; 15(11):e0241971. PubMed ID: 33201906
[TBL] [Abstract][Full Text] [Related]
27. Molecular surveillance and clinical outcomes of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae infections.
Huang SR; Liu MF; Lin CF; Shi ZY
J Microbiol Immunol Infect; 2014 Jun; 47(3):187-96. PubMed ID: 23200553
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: A systematic review.
Kedišaletše M; Phumuzile D; Angela D; Andrew W; Mae NF
J Glob Antimicrob Resist; 2023 Dec; 35():297-306. PubMed ID: 37879456
[TBL] [Abstract][Full Text] [Related]
29. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
30. Carbapenem-resistant Klebsiella pneumoniae colonization in pediatric and neonatal intensive care units: risk factors for progression to infection.
Akturk H; Sutcu M; Somer A; Aydın D; Cihan R; Ozdemir A; Coban A; Ince Z; Citak A; Salman N
Braz J Infect Dis; 2016; 20(2):134-40. PubMed ID: 26867474
[TBL] [Abstract][Full Text] [Related]
31. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study.
McConville TH; Sullivan SB; Gomez-Simmonds A; Whittier S; Uhlemann AC
PLoS One; 2017; 12(10):e0186195. PubMed ID: 29023567
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology and clinical characteristics of patients with carbapenem-resistant enterobacterales infections: experience from a large tertiary care center in a developing country.
Aiesh BM; Maali Y; Qandeel F; Omarya S; Taha SA; Sholi S; Sabateen A; Taha AA; Zyoud SH
BMC Infect Dis; 2023 Oct; 23(1):644. PubMed ID: 37784023
[TBL] [Abstract][Full Text] [Related]
34. Performance of two methods of carbapenem-resistant Enterobacterales surveillance on a kidney transplant ward: selective culture of and real-time PCR directly from rectal swabs.
Freire MP; de Oliveira Garcia D; Lima SG; Pea CRD; Reusing Junior JO; Spadão F; Cury AP; Rossi F; Nahas WC; David-Neto E; Pierrotti LC
Infection; 2022 Dec; 50(6):1525-1533. PubMed ID: 35534755
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of carbapenem-resistant
Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
[No Abstract] [Full Text] [Related]
36. Genetic Characterization of Carbapenem-Resistant Enterobacteriaceae and the Spread of Carbapenem-Resistant Klebsiella pneumonia ST340 at a University Hospital in Thailand.
Netikul T; Kiratisin P
PLoS One; 2015; 10(9):e0139116. PubMed ID: 26407326
[TBL] [Abstract][Full Text] [Related]
37. Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.
Cao W; Zhang J; Bian Z; Li L; Zhang S; Qin Y; Wan D; Jiang Z; Zhang R
Infect Drug Resist; 2022; 15():5993-6006. PubMed ID: 36262593
[TBL] [Abstract][Full Text] [Related]
38. Different Effects of Antibiotics on
Chen J; Xiang Q; Wu JY; Huang XB; Wang C; Wei DQ; Lv Y
Microb Drug Resist; 2022 Jun; 28(6):660-669. PubMed ID: 35639423
[No Abstract] [Full Text] [Related]
39. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.
Kontopoulou K; Iosifidis E; Antoniadou E; Tasioudis P; Petinaki E; Malli E; Metallidis S; Vatopoulos A; Malisiovas N
J Med Microbiol; 2019 Mar; 68(3):326-335. PubMed ID: 30688629
[TBL] [Abstract][Full Text] [Related]
40. [Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation].
Huang XL; Wu SH; Shi PF; Xu LH; Chen C; Xie YP; Gao DQ; Chen K; Tan JF; Liu LR; Xu Y; Yang F; Yu MX; Wang SY; Qian SX
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):932-936. PubMed ID: 33333697
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
